Fabio Berti / Shutterstock.com
26 October 2020AmericasSarah Morgan
Canada's drug pricing plan prompts backlash
The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Big Pharma
14 December 2020 Micheline Gravelle and Iris Cheung of Bereskin & Parr provide an update on the final version of guidelines issued by Canada’s federal drug price regulator—and its likely implications.
Americas
9 September 2019 Innovative Medicines Canada, an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.
Big Pharma
27 March 2020 Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.
Editor's picks
Editor's picks
Big Pharma
14 December 2020 Micheline Gravelle and Iris Cheung of Bereskin & Parr provide an update on the final version of guidelines issued by Canada’s federal drug price regulator—and its likely implications.
Americas
9 September 2019 Innovative Medicines Canada, an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.
Big Pharma
27 March 2020 Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.
Big Pharma
14 December 2020 Micheline Gravelle and Iris Cheung of Bereskin & Parr provide an update on the final version of guidelines issued by Canada’s federal drug price regulator—and its likely implications.
Americas
9 September 2019 Innovative Medicines Canada, an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.
Big Pharma
27 March 2020 Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.